Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Pierre Fabre investigates ACAT inhibitors

Sep. 20, 1996

Wakamoto claims diclofenac eyedrop formulation

Sep. 20, 1996

Pfizer describes anticancer application for known antidepressant

Sep. 20, 1996

Novel anticancer tyrosine kinase inhibitors from Pharmacia & Upjohn

Sep. 20, 1996

HEK4-binding protein from Amgen

Sep. 20, 1996

RPR reports novel protein farnesyltransferase inhibitors

Sep. 20, 1996

CI-958 for treatment of prostate cancer

Sep. 20, 1996

SAMDC inhibitors from Ciba-Geigy

Sep. 20, 1996

Nitrogen mustard prodrugs from CRC Technology

Sep. 20, 1996

New formulation of ciclosporin

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...